Hjem › Post-COVID-tilstander (lang-COVID) › South Carolina
Kliniske studier for Post-COVID-tilstander (lang-COVID) i South Carolina
4 studier for Post-COVID-tilstander (lang-COVID) søker deltakere på steder i South Carolina.
Byer i South Carolina
Offisiell studietekst (engelsk)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Greenville
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Medical University of South Carolina Infectious Disease Clinic, Charleston
- Medical University of South Carolina Investigational Drug Services (IDS), Charleston
- Medical University of South Carolina Investigational Drug Services Pharmacy, Charleston
- og 3 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Medical University of South Carolina Ashley River Tower, Charleston
- Medical University of South Carolina - SCTR Research Nexus, Charleston
- Medical University of South Carolina, Charleston
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06679140Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
- Medical University of South Carolina, Charleston
RekruttererFase 2/3
Alder 18 til 65 · Alle kjønn · Oppdatert 2. apr. 2026 · NCT05855369Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.